2025-04-01 2026-03-31 false No description of principal activity Capium Accounts Production 1.1 11683202 2025-04-01 2026-03-31 11683202 bus:FullAccounts 2025-04-01 2026-03-31 11683202 bus:Micro-entities 2025-04-01 2026-03-31 11683202 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 11683202 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 11683202 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 11683202 2025-04-01 2026-03-31 11683202 2026-03-31 11683202 bus:RegisteredOffice 2025-04-01 2026-03-31 11683202 core:WithinOneYear 2026-03-31 11683202 core:AfterOneYear 2026-03-31 11683202 1 2025-04-01 2026-03-31 11683202 bus:Director1 2025-04-01 2026-03-31 11683202 bus:Director1 2026-03-31 11683202 bus:Director2 2025-04-01 2026-03-31 11683202 bus:Director2 2026-03-31 11683202 2024-04-01 11683202 bus:LeadAgentIfApplicable 2025-04-01 2026-03-31 11683202 2025-03-31 11683202 core:CostValuation core:Non-currentFinancialInstruments 2026-03-31 11683202 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 11683202 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-03-31 11683202 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 11683202 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 11683202 core:Non-currentFinancialInstruments 2026-03-31 11683202 core:Non-currentFinancialInstruments 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11683202
England and Wales

 

 

 

ONCOCDX LTD.


Unaudited Financial Statements
 


Period of accounts

Start date: 01 April 2025

End date: 31 March 2026
Directors Rafal Damian URNIAZ
Aleksandra URNIAZ
Registered Number 11683202
Registered Office 167-169 Great Portland Street
5th Floor
London
England
W1W 5PF
1
Director's report and financial statements
The directors present his/her/their report and accounts for the year ended 31 March 2026.
Directors
The directors who served the company throughout the year were as follows:
Rafal Damian URNIAZ
Aleksandra URNIAZ

This report was approved by the board and signed on its behalf by:


----------------------------------
Rafal Damian URNIAZ
Director

Date approved: 12 October 2026
2
 
 

 
2026
£
Turnover 78,090 
Cost of raw materials and consumables (72,618)
Staff costs (6,800)
Other charges (7,613)
Profit/Loss for the financial year (8,941)
 
3
  2026
    £ £
Current assets (99)  
Creditors: amount falling due within one year (11,838)  
Net current assets   (11,937)
Total assets less current liabilities   (11,937)
Net assets   (11,937)
 

     
Capital and reserves   (11,937)
 
NOTES TO THE ACCOUNTS

General Information
OncoCDx Ltd. is a private company, limited by shares, registered in England and Wales, registration number 11683202, registration address 167-169 Great Portland Street, 5th Floor, London, England, W1W 5PF .

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees


Average number of employees during the year was 2.


For the year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime.
The financial statements were approved by the board of directors on 12 October 2026 and were signed on its behalf by:


--------------------------------
Rafal Damian URNIAZ
Director
4